Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Tokyo Big Sight

11 nov 2018 9:30 a.m. - 13 nov 2018 5:40 p.m.

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

15th DIA Japan Annual Meeting 2018

Innovative technologies such as AI, big data/genomics, and cell/gene therapies are poised to transform healthcare product development across the globe – join us to discuss these topics.

[V5-S3] New Pharmaceutical Technical Innovation - Continuous Manufacturing and its Driving Forces

Session Chair(s)

Hirofumi  Takeuchi, PhD

Hirofumi Takeuchi, PhD

Professor, Laboratory of Pharmaceutical Engineering

Gifu Pharmaceutical University, Japan

“Continuous Manufacturing” is a quite new innovative technology in the pharmaceutical industry, which will achieve the big cost reduction in manufacturing of the pharmaceutical drugs, while the continuous manufacturing is a major process in other industries, e.g., petroleum or food products. The continuous manufacturing is a process that the material(s) and product are continuously charged and discharged from the system, respectively, throughout the duration of the process in the drug manufacturing. In this session, the key experts from the regulator, industry and academia will discuss the regulatory and quality considerations for the continuous manufacturing and its driving forces.

Speaker(s)

Kohei  Tahara, PhD

Continuous Spherical Crystallization Used for Integrated Pharmaceutical Manufacturing

Kohei Tahara, PhD

Gifu Pharmaceutical University, Japan

Associate Professor, Laboratory of Pharmaceutical Engineering

Ryutaro  Shimono

Janssen's Experience to Introduce Innovative Continuous Manufacturing (CM)

Ryutaro Shimono

Janssen Pharmaceutical K.K., Japan

CMC Sciences Department, Regulatory Affairs Division, R&D Division

Issei  Takayama, DrSc

Current Regulatory Considerations and Challenges for Continuous Manufacturing of Pharmaceuticals

Issei Takayama, DrSc

Pharmaceuticals and Medical Devices Agency (PMDA), Japan, Japan

Reviewer, Office of New Drug IV

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.